151 related articles for article (PubMed ID: 35937944)
41. An Epithelial-Mesenchymal Transition (EMT) Preoperative Nomogram for Prediction of Lymph Node Metastasis in Bladder Cancer (BLCA).
Cao R; Ma B; Wang G; Xiong Y; Tian Y; Yuan L
Dis Markers; 2020; 2020():8833972. PubMed ID: 33204364
[TBL] [Abstract][Full Text] [Related]
42. A Novel Gene Prognostic Signature Based on Differential DNA Methylation in Breast Cancer.
Zhu C; Zhang S; Liu D; Wang Q; Yang N; Zheng Z; Wu Q; Zhou Y
Front Genet; 2021; 12():742578. PubMed ID: 34956313
[No Abstract] [Full Text] [Related]
43. A four-miRNA signature as a novel biomarker for predicting survival in endometrial cancer.
Wu YS; Lin H; Chen D; Yi Z; Zeng B; Jiang Y; Ren G
Gene; 2019 May; 697():86-93. PubMed ID: 30779946
[TBL] [Abstract][Full Text] [Related]
44. Development and Validation of an 8-Gene Signature to Improve Survival Prediction of Colorectal Cancer.
Zhou L; Yu Y; Wen R; Zheng K; Jiang S; Zhu X; Sui J; Gong H; Lou Z; Hao L; Yu G; Zhang W
Front Oncol; 2022; 12():863094. PubMed ID: 35619909
[TBL] [Abstract][Full Text] [Related]
45. Development and Validation of Prognostic Nomogram for Elderly Breast Cancer: A Large-Cohort Retrospective Study.
Li G; Zhang D
Int J Gen Med; 2022; 15():87-101. PubMed ID: 35018116
[TBL] [Abstract][Full Text] [Related]
46. An immune-related prognostic signature for predicting breast cancer recurrence.
Tian Z; Tang J; Liao X; Yang Q; Wu Y; Wu G
Cancer Med; 2020 Oct; 9(20):7672-7685. PubMed ID: 32841536
[TBL] [Abstract][Full Text] [Related]
47. Identification of miRNA-Based Signature as a Novel Potential Prognostic Biomarker in Patients with Breast Cancer.
Tang J; Ma W; Zeng Q; Tan J; Cao K; Luo L
Dis Markers; 2019; 2019():3815952. PubMed ID: 31976020
[TBL] [Abstract][Full Text] [Related]
48. Identification of a novel metabolism-related gene signature associated with the survival of bladder cancer.
Li X; Fu S; Huang Y; Luan T; Wang H; Wang J
BMC Cancer; 2021 Nov; 21(1):1267. PubMed ID: 34819038
[TBL] [Abstract][Full Text] [Related]
49. Systemic Analysis of the Prognosis-Associated Alternative Polyadenylation Events in Breast Cancer.
Zhang Y; Wang Y; Li C; Jiang T
Front Genet; 2020; 11():590770. PubMed ID: 33329736
[TBL] [Abstract][Full Text] [Related]
50. Identification of Epithelial Mesenchymal Transition-Related lncRNAs Associated with Prognosis and Tumor Immune Microenvironment of Hepatocellular Carcinoma.
Zhou Y; Wang L; Zhang W; Ma J; Zhang Z; Yang M; Yu J; Luo J; Yan Z
Dis Markers; 2022; 2022():6335155. PubMed ID: 35111268
[TBL] [Abstract][Full Text] [Related]
51. A nomogram based on CENPP expression for survival prediction in breast cancer.
Chen H; Pu S; Yu S; Liao X; He J; Zhang H
Gland Surg; 2021 Jun; 10(6):1874-1888. PubMed ID: 34268072
[TBL] [Abstract][Full Text] [Related]
52. Five EMT-Related Gene Signatures Predict Acute Myeloid Leukemia Patient Outcome.
Qi J; Yan J; Idrees M; Almutairi SM; Rasheed RA; Hussein UA; Abdel-Maksoud MA; Wang R; Huang J; Huang C; Wang N; Huang D; Hui Y; Li C
Dis Markers; 2022; 2022():7826393. PubMed ID: 36246561
[TBL] [Abstract][Full Text] [Related]
53. Identification and Validation of an Individualized EMT-Related Prognostic Risk Score Formula in Gastric Adenocarcinoma Patients.
Zhang D; Zhou S; Liu B
Biomed Res Int; 2020; 2020():7082408. PubMed ID: 32309437
[TBL] [Abstract][Full Text] [Related]
54. Comprehensive Analysis to Identify the Epithelial-Mesenchymal Transition-Related Immune Signatures as a Prognostic and Therapeutic Biomarkers in Hepatocellular Carcinoma.
Wu G; Yang Y; Zhu Y; Li Y; Zhai Z; An L; Liu M; Zheng Y; Wang Y; Zhou Y; Guo Q
Front Surg; 2021; 8():742443. PubMed ID: 34722623
[No Abstract] [Full Text] [Related]
55. Identification of Epithelial-Mesenchymal Transition-Related lncRNA With Prognosis and Molecular Subtypes in Clear Cell Renal Cell Carcinoma.
Zhong W; Zhang F; Huang C; Lin Y; Huang J
Front Oncol; 2020; 10():591254. PubMed ID: 33324563
[TBL] [Abstract][Full Text] [Related]
56. CDKN1C as a prognostic biomarker correlated with immune infiltrates and therapeutic responses in breast cancer patients.
Lai J; Lin X; Cao F; Mok H; Chen B; Liao N
J Cell Mol Med; 2021 Oct; 25(19):9390-9401. PubMed ID: 34464504
[TBL] [Abstract][Full Text] [Related]
57. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
[TBL] [Abstract][Full Text] [Related]
58. Nomogram based on autophagy related genes for predicting the survival in melanoma.
Deng G; Wang W; Li Y; Sun H; Chen X; Zeng F
BMC Cancer; 2021 Nov; 21(1):1258. PubMed ID: 34809598
[TBL] [Abstract][Full Text] [Related]
59. An epithelial-mesenchymal transition-related 5-gene signature predicting the prognosis of hepatocellular carcinoma patients.
Zhu G; Xia H; Tang Q; Bi F
Cancer Cell Int; 2021 Mar; 21(1):166. PubMed ID: 33712026
[TBL] [Abstract][Full Text] [Related]
60. Identification and Validation of EMT-Related lncRNA Prognostic Signature for Colorectal Cancer.
Li D; Lin X; Chen B; Ma Z; Zeng Y; Wang H
Front Genet; 2021; 12():723802. PubMed ID: 34659346
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
